SEC Form 4 · accession 0001493152-17-006778
VBI Vaccines Inc/BC · VBIV
Statement of changes in beneficial ownership, as filed. Original on EDGAR ↗
Reporting owner
Sam Chawla
Director
Period of report
Jun 14, 2017
Accepted (ET)
Jun 16, 2017 · 5:57 pm EDT
Rule 10b5-1 plan
unknown — predates the checkbox
Issuer CIK
0000764195
Table I — non-derivative securities
| Security | Date | Code | Shares | Price | A/D | Owned after | D/I | Nature of ownership |
|---|---|---|---|---|---|---|---|---|
| Common Shares, no par value per shareF1 | Jun 14, 2017 | M | 12,500 | — | A | 25,000 | D | |
| Common Shares, no par value per shareF2 | holding | — | — | — | 6,565,843 | I | See Footnote |
Table II — derivative securities
| Security | Conv. / exercise price | Date | Code | Shares | A/D | Exercisable | Expires | Underlying | Underlying shares | Owned after | D/I |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Restricted Stock Units (RSUs)F1,F3 | — | Jun 14, 2017 | M | 12,500 | D | — | Jun 14, 2026 | Common Shares | 12,500 | 25,000 | D |
Explanation of responses
- F1Each restricted stock unit represents the right to receive, at settlement, one common share. This transaction represents the settlement of restricted stock units in common shares on their scheduled vesting date.
- F2These shares are held of record by Perceptive Life Sciences Master Fund Ltd. and Titan-Perc Ltd, a related entity. As a Portfolio Manager of Perceptive Advisors LLC, a related entity to Perceptive Life Sciences Master Fund Ltd. and Titan-Perc Ltd, Mr. Chawla has voting and dispositive control over any securities owned of record by Perceptive Life Sciences Master Fund Ltd. and Titan-Perc Ltd.
- F3The restricted stock units vest 1/3 per year over 3 years, beginning on June 14, 2017, subject to continued service through each vesting date.